Glycogen Synthase Kinase-3 Inhibition Sensitizes Pancreatic Cancer Cells to TRAIL-Induced Apoptosis
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Glycogen Synthase Kinase-3 Inhibition Sensitizes Pancreatic Cancer Cells to TRAIL-Induced Apoptosis
Authors
Keywords
-
Journal
PLoS One
Volume 7, Issue 7, Pages e41102
Publisher
Public Library of Science (PLoS)
Online
2012-07-20
DOI
10.1371/journal.pone.0041102
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Small Molecule Inhibitors of Bcl-2 Family Proteins for Pancreatic Cancer Therapy
- (2011) Ashiq Masood et al. Cancers
- Death Receptor Agonists as a Targeted Therapy for Cancer
- (2010) J. Wiezorek et al. CLINICAL CANCER RESEARCH
- Glycogen synthase kinase-3 inhibition disrupts nuclear factor-kappaB activity in pancreatic cancer, but fails to sensitize to gemcitabine chemotherapy
- (2009) Shadi Mamaghani et al. BMC CANCER
- Inhibition of the Sodium Potassium Adenosine Triphosphatase Pump Sensitizes Cancer Cells to Anoikis and Prevents Distant Tumor Formation
- (2009) C. D. Simpson et al. CANCER RESEARCH
- TRAIL receptor upregulation and the implication of KRAS/BRAF mutations in human colon cancer tumors
- (2009) Eftychia Oikonomou et al. INTERNATIONAL JOURNAL OF CANCER
- The Role of Nuclear Factor κB in Pancreatic Cancer and the Clinical Applications of Targeted Therapy
- (2009) Bryan Holcomb et al. PANCREAS
- Glycogen synthase kinase-3 inhibitors augment TRAIL-induced apoptotic death in human hepatoma cells
- (2008) Eléonore Beurel et al. BIOCHEMICAL PHARMACOLOGY
- Small molecule XIAP inhibitors cooperate with TRAIL to induce apoptosis in childhood acute leukemia cells and overcome Bcl-2-mediated resistance
- (2008) M. Fakler et al. BLOOD
- Mcl-1: A Gateway to TRAIL Sensitization
- (2008) S.-H. Kim et al. CANCER RESEARCH
- Targeting XIAP Bypasses Bcl-2-Mediated Resistance to TRAIL and Cooperates with TRAIL to Suppress Pancreatic Cancer Growth In vitro and In vivo
- (2008) M. Vogler et al. CANCER RESEARCH
- Apoptosis resistance in epithelial tumors is mediated by tumor-cell-derived interleukin-4
- (2008) M Todaro et al. CELL DEATH AND DIFFERENTIATION
- OPG Is Regulated by -Catenin and Mediates Resistance to TRAIL-Induced Apoptosis in Colon Cancer
- (2008) E. N. De Toni et al. CLINICAL CANCER RESEARCH
- Death receptors as targets for anti-cancer therapy
- (2008) Kerstin Papenfuss et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- To kill a tumor cell: the potential of proapoptotic receptor agonists
- (2008) Avi Ashkenazi et al. JOURNAL OF CLINICAL INVESTIGATION
- Ligand-Based Targeting of Apoptosis in Cancer: The Potential of Recombinant Human Apoptosis Ligand 2/Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand (rhApo2L/TRAIL)
- (2008) Avi Ashkenazi et al. JOURNAL OF CLINICAL ONCOLOGY
- Directing cancer cells to self-destruct with pro-apoptotic receptor agonists
- (2008) Avi Ashkenazi NATURE REVIEWS DRUG DISCOVERY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search